Delivery Order SPE2DB20D1100-SPE2DB24FC0Z9
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 ml pens. The award, valued at $11,265.08, was made on a firm-fixed price basis without a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) is for the delivery of Trulicity 0.75 mg/0.5 ml pens for $5,805.60. The contract has a completion date of June 18, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 0.75 mg/0.5 ml pens. The $2,778.60 firm fixed-price contract has a completion date of May 28, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award, valued at $1,451.40, is for the delivery of Trulicity 0.75 mg/0.5 ml pens and has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 4.5 mg/0.5 ml pens. The $11,658.64 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) on June 24, 2024, with a completion date of June 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems....
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $5,955.18 fixed-price delivery order for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical to provide a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 1.5 mg/0.5 mL pens. The contract has a ceiling value of $3,047.94 and a period of performance through July 3, 2024. It was awarded as a firm-fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 0.75 mg/0.5 ml pens (0.5 ml) to the Defense Logistics Agency (DLA). The $1,306.26 firm-fixed price delivery order has a completion date of May 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The award, valued at $2,902.80, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. The single-award contract, valued at $2,902.80, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FC0Z9Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $20,256.48, is for the delivery of Trulicity 0.75 mg/0.5 ml pens. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a firm fixed-price delivery order with a completion date of June 5, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense and Veterans Affairs healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical supplies, as well as a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar items. This specific award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.3k | 6/4/24 |